Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine to reduce fumarate adverse effects in severe chronic plaque psoriasis
NL-OMON20745Recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in plaque psoriasis and psoriasis comparing Fumarates + levocetirizine with Fumarates + placebo (2 arms). Primary endpoint: PASI score. Started Sep 2006; status: recruiting.
02
Drugs
levocetirizine
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on NL-OMON20745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20745.